REGENERON PHARMACEUTICALS, INC. - Common Stock (REGN)
CUSIP: 75886F107
Q4 2024 13F Holders as of 31 Dec 2024
- Type / Class
- Equity / Common Stock
- Shares outstanding
- 103,945,862
- Total 13F shares
- 93,286,684
- Share change
- -152,769
- Total reported value
- $66,492,644,189
- Put/Call ratio
- 91%
- Price per share
- $712.33
- Number of holders
- 1,299
- Value change
- -$479,615,848
- Number of buys
- 550
- Number of sells
- 702
Quarterly Holders Quick Answers
What is CUSIP 75886F107?
CUSIP 75886F107 identifies REGN - REGENERON PHARMACEUTICALS, INC. - Common Stock in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 75886F107:
Top shareholders of REGN - REGENERON PHARMACEUTICALS, INC. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| FMR LLC |
13F
|
Company |
10%
|
10,362,701
|
$10,893,686,374 | — | 30 Sep 2024 | |
| VANGUARD GROUP INC |
13F
|
Company |
9%
|
9,320,290
|
$9,797,861,658 | — | 30 Sep 2024 | |
| BlackRock, Inc. |
13F
|
Company |
8.2%
|
8,480,262
|
$8,914,790,432 | — | 30 Sep 2024 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
7.2%
|
7,489,500
|
$7,873,263,947 | — | 30 Sep 2024 | |
| STATE STREET CORP |
13F
|
Company |
4.7%
|
4,902,404
|
$5,153,603,181 | — | 30 Sep 2024 | |
| Capital World Investors |
13F
|
Company |
4.1%
|
4,298,387
|
$4,518,578,191 | — | 30 Sep 2024 | |
| Capital International Investors |
13F
|
Company |
3.2%
|
3,346,395
|
$3,517,426,656 | — | 30 Sep 2024 | |
| DODGE & COX |
13F
|
Company |
2.2%
|
2,311,935
|
$2,430,398,549 | — | 30 Sep 2024 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
2.2%
|
2,272,261
|
$2,380,748,456 | — | 30 Sep 2024 | |
| FRANKLIN RESOURCES INC |
13F
|
Company |
1.8%
|
1,896,086
|
$1,912,695,291 | — | 30 Sep 2024 | |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
|
Company |
1.2%
|
1,275,303
|
$1,340,650,000 | — | 30 Sep 2024 | |
| MORGAN STANLEY |
13F
|
Company |
1.1%
|
1,185,488
|
$1,246,236,984 | — | 30 Sep 2024 | |
| LOOMIS SAYLES & CO L P |
13F
|
Company |
1.1%
|
1,181,352
|
$1,241,884,000 | — | 30 Sep 2024 | |
| Invesco Ltd. |
13F
|
Company |
1.1%
|
1,161,173
|
$1,220,671,977 | — | 30 Sep 2024 | |
| NORGES BANK |
13F
|
Company |
1.1%
|
1,122,106
|
$1,179,602,711 | — | 30 Sep 2024 | |
| Amundi |
13F
|
Individual |
1%
|
1,064,246
|
$1,070,089,112 | — | 30 Sep 2024 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.96%
|
993,237
|
$1,044,130,815 | — | 30 Sep 2024 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.88%
|
918,645
|
$965,716,370 | — | 30 Sep 2024 | |
| Legal & General Group Plc |
13F
|
Company |
0.76%
|
785,094
|
$825,326,059 | — | 30 Sep 2024 | |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC |
13F
|
Company |
0.73%
|
755,112
|
$793,803,938 | — | 30 Sep 2024 | |
| AMERICAN CENTURY COMPANIES INC |
13F
|
Company |
0.71%
|
738,495
|
$776,336,334 | — | 30 Sep 2024 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.69%
|
715,076
|
$751,716,507 | — | 30 Sep 2024 | |
| Nuveen Asset Management, LLC |
13F
|
Company |
0.66%
|
686,639
|
$721,822,382 | — | 30 Sep 2024 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.65%
|
673,261
|
$707,759,195 | — | 30 Sep 2024 | |
| Capital Research Global Investors |
13F
|
Company |
0.62%
|
644,868
|
$677,911,036 | — | 30 Sep 2024 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.59%
|
609,043
|
$640,250,311 | — | 30 Sep 2024 | |
| ALLIANCEBERNSTEIN L.P. |
13F
|
Company |
0.56%
|
579,518
|
$609,212,502 | — | 30 Sep 2024 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
0.55%
|
570,064
|
$599,244,695 | — | 30 Sep 2024 | |
| MASSACHUSETTS FINANCIAL SERVICES CO /MA/ |
13F
|
Company |
0.49%
|
514,265
|
$540,615,938 | — | 30 Sep 2024 | |
| BNP Paribas Asset Management Holding S.A. |
13F
|
Company |
0.47%
|
485,847
|
$510,741,000 | — | 30 Sep 2024 | |
| Neuberger Berman Group LLC |
13F
|
Company |
0.43%
|
449,590
|
$472,627,052 | — | 30 Sep 2024 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
0.43%
|
442,940
|
$465,636,245 | — | 30 Sep 2024 | |
| WELLINGTON MANAGEMENT GROUP LLP |
13F
|
Company |
0.42%
|
440,609
|
$463,185,805 | — | 30 Sep 2024 | |
| VAGELOS P ROY |
3/4/5
|
Director |
—
class O/S missing
|
467,104
|
$444,337,350 | — | 03 Apr 2023 | |
| BARCLAYS PLC |
13F
|
Company |
0.4%
|
412,747
|
$433,896,156 | — | 30 Sep 2024 | |
| CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM |
13F
|
Company |
0.36%
|
371,638
|
$390,680,731 | — | 30 Sep 2024 | |
| AMERIPRISE FINANCIAL INC |
13F
|
Company |
0.35%
|
366,759
|
$385,713,467 | — | 30 Sep 2024 | |
| HSBC HOLDINGS PLC |
13F
|
Company |
0.34%
|
357,084
|
$374,998,382 | — | 30 Sep 2024 | |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE |
13F
|
Company |
0.33%
|
338,044
|
$355,365,375 | — | 30 Sep 2024 | |
| TD ASSET MANAGEMENT INC |
13F
|
Company |
0.32%
|
330,067
|
$344,157,560 | — | 30 Sep 2024 | |
| Swiss National Bank |
13F
|
Company |
0.31%
|
321,600
|
$338,078,784 | — | 30 Sep 2024 | |
| Sumitomo Mitsui Trust Group, Inc. |
13F
|
Company |
0.29%
|
301,508
|
$316,957,270 | — | 30 Sep 2024 | |
| BNP PARIBAS FINANCIAL MARKETS |
13F
|
Company |
0.28%
|
295,412
|
$310,548,911 | — | 30 Sep 2024 | |
| FIRST TRUST ADVISORS LP |
13F
|
Company |
0.28%
|
291,941
|
$306,899,524 | — | 30 Sep 2024 | |
| Pictet Asset Management Holding SA |
13F
|
Company |
0.28%
|
286,545
|
$300,426,858 | — | 30 Sep 2024 | |
| UBS Group AG |
13F
|
Company |
0.26%
|
271,850
|
$285,779,594 | — | 30 Sep 2024 | |
| D. E. Shaw & Co., Inc. |
13F
|
Company |
0.26%
|
266,236
|
$279,877,933 | — | 30 Sep 2024 | |
| ROYAL BANK OF CANADA |
13F
|
Company |
0.25%
|
261,440
|
$274,838,000 | — | 30 Sep 2024 | |
| S.c.a. Candriam |
13F
|
Individual |
0.24%
|
252,525
|
$265,452,488 | — | 30 Sep 2024 | |
| Chevy Chase Trust Holdings, LLC |
13F
|
Company |
0.23%
|
238,379
|
$250,593,540 | — | 30 Sep 2024 |
Institutional Holders of REGENERON PHARMACEUTICALS, INC. - Common Stock (REGN) as of Q4 2024
As of 31 Dec 2024,
REGENERON PHARMACEUTICALS, INC. - Common Stock (REGN) was held by
1,299 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
93,286,684 shares.
The largest 10 holders included
VANGUARD GROUP INC, BlackRock, Inc., FMR LLC, JPMORGAN CHASE & CO, STATE STREET CORP, Capital International Investors, Capital World Investors, GEODE CAPITAL MANAGEMENT, LLC, Dodge & Cox, and PRICE T ROWE ASSOCIATES INC /MD/.
This page lists
1,305
institutional shareholders reporting positions in this security
for the Q4 2024 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q4 2024 vs Q3 2024 Across Filers
Q3 2024 holders
1,377
Q4 2024 holders
1,299
Holder diff
-78
| Investor | Q3 2024 Shares | Q4 2024 Shares | Share Diff | Share Chg % | Q3 2024 Value $ | Q4 2024 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.